Response: anticipating new medications.
Response: anticipating new medications.
复制标题
回应：期待新药。
DOI：
10.1151/ascp084236
复制
发表时间：
2008
影响因子：
3.7
通讯作者：
Roll,John
中科院分区：
文献类型：
--
作者：
Bogenschutz,MichaelP;DeMarzo,LawrenceJ;Roll,John
Lawrence DeMarzo: My agency, House of the Crossroads, like other drug-free com munity-based agencies, has historically cho sen not to use medications in its treatment regimens. That is changing now, through our involvement in NIDA’s Clinical Trials Network and our acquaintance with litera ture like Dr. Kampman’s article (Kampman, 2008).Much has changed since we started Cross roads. We know a lot more about addiction and treatment than we did 40 years ago. Although the agency is not using any med ications yet, we are considering implementing a methadone-to-abstinence model for heroin abusers. Methadone appeals to us, because we have seen that it works, and because it seems to be a service line that produces sta ble utilization and retention, which a feefor-service structure needs to generate rev enue to cover the cost of care. I was impressed and encouraged by Dr. Kampman’s positive outlook on the potential for medications to treat stimulant abuse. The drugs in this class, particularly crack cocaine and metham phetamine, have had the most devastating effects on our community and present the greatest challenge to us in terms of provid ing effective treatment.
